论文部分内容阅读
目的了解新疆地区汉族、维吾尔族成年人代谢综合征(MS)流行病学特点。方法应用四阶段整群随机抽样法,于2007年6月~2010年3月在新疆抽取乌鲁木齐市、克拉玛依市、阜康市、吐鲁番地区、和田地区、伊犁哈萨克族自治州年龄>35岁的样本,统计汉族和维吾尔族不同民族组、不同年龄组人群的代谢综合征患病率,并进行相关因素分析。结果共调查10 242人,汉族5 573人,维吾尔族4 669人,汉族患代谢综合征1 896人,维吾尔族患代谢综合征1 344人,新疆地区汉族人群和维吾尔族人群的代谢综合征的总患病率为30.7%,年龄构成标化后为28.9%;根据IDF标准,汉族人群在各年龄段的MS患病率均高于维吾尔族人群,并且随着年龄增高逐渐增高,维吾尔族人群患病率在55~64岁组达到最高,以后逐渐下降;汉族男性人群代谢综合征患病率为41.5%,女性人群为21.9%,总患病率为31.3%,经年龄标化患病率为31.1%;维吾尔族男性人群代谢综合征患病率为28.6%,女性人群为27.9%,总患病率为28.2%,经年龄标化患病率为27.8%。结论新疆地区成年人MS患病率高于全国水平,亟需制定面向全国的预防、检测和治疗MS的卫生策略,以降低心血管疾病的社会负担。
Objective To understand the epidemiological characteristics of metabolic syndrome (MS) in Han and Uighur adults in Xinjiang region. Methods A four-stage cluster random sampling method was used to collect samples from Urumqi, Karamay, Fukang, Turpan, Hetian and Ili Kazak Autonomous Prefecture aged> 35 years from June 2007 to March 2010 in Xinjiang Uygur Autonomous Region. Statistics Han and Uygur ethnic groups of different age groups in the prevalence of metabolic syndrome, and related factors. Results A total of 10 242 people, 5 573 Han people, 4 669 Uygur people, 1 896 Han people suffering from metabolic syndrome, 1 344 Han people with metabolic syndrome, Xinjiang Han population and Uygur population were diagnosed as metabolic syndrome The overall prevalence rate was 30.7%, and the age was normalized to 28.9%. According to the IDF standard, the prevalence of MS in all age groups was higher than that of Uyghur population, and gradually increased with age. The Uyghur population The prevalence rate reached the highest in the group of 55-64 years old, then decreased gradually; The prevalence of metabolic syndrome was 41.5% in Han male population and 21.9% in female population, the total prevalence rate was 31.3%. The age-standardized prevalence rate Was 31.1%. The prevalence of metabolic syndrome was 28.6% in Uygur men and 27.9% in women, with a total prevalence of 28.2% and an age-standardized prevalence of 27.8%. Conclusion The prevalence of MS among adults in Xinjiang is higher than the national average. It is urgent to formulate a national health strategy to prevent, detect and treat MS in order to reduce the social burden of cardiovascular diseases.